About
TheraBionic Inc. is an innovative medical device company focused on transforming the lives of patients with difficult to treat cancers. TheraBionic Inc. patented low-level, tumor-specific radio frequencies administered via the TheraBionic P1 device is FDA approved in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. The results of more than two decades of studies have indicated that the tumor-specific radio frequencies are effective in tumor shrinkage, blocking new cancer cell growth, and overall increased survival rates.
Technologies
YouTube
WordPress.org
Typekit
Mobile Friendly
Google Tag Manager
Vimeo
Multilingual
Squarespace ECommerce
Viewpoint
Keywords
oncology
hepatocellular carcinoma
liver cancer
systemic targeted therapy
medical equipment manufacturing
systemic electromagnetic therapy
medical devices
clinical trials
services
cancer therapy
cancer treatment
non-toxic cancer therapy
tumor-specific frequencies
cav3.2 t-type channels
portable device
patient care
tumor-specific radio frequencies
pulse pressure response
amplitude-modulated rf emf
radiofrequency electromagnetic fields
bio-electromagnetics
non-invasive treatment
medical device
systemic electromagnetic delivery
healthcare
safety and efficacy
medical equipment and supplies manufacturing
fda approved
hospital & health care
health care
Company Information
-
Employees 3
-
Founded 2018
Location
Bloomfield Hills, Michigan, United States, 48302
